Lipocine Announces Tentative Approval of TLANDO™ ...Middle East

PR Newswire - News
Lipocine Announces Tentative Approval of TLANDO™
SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has granted tentative approval to TLANDO, its oral...

Hence then, the article about lipocine announces tentative approval of tlando was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lipocine Announces Tentative Approval of TLANDO™ )

Apple Storegoogle play

Last updated :

Also on site :